ClinicalTrials.Veeva

Menu

EverFlex™ Self-expanding Peripheral Stent With Entrust™ Delivery System Clinical Study

Medtronic logo

Medtronic

Status

Completed

Conditions

Peripheral Arterial Diseases

Treatments

Device: EverFlex™ stent with Entrust™ delivery system

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

The purpose of this study is to collect acute confirmatory data to evaluate technical success and acute safety of the EverFlex™ self-expanding peripheral stent with Entrust™ delivery system.

Enrollment

34 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Has stenotic, restenotic (from PTA or adjunct therapy, not including stents or stent grafts),
  • or occluded lesion(s) located in the superficial femoral artery (SFA) and/or proximal popliteal artery (PPA) suitable for primary stenting.

Exclusion criteria

  • Has undergone previous implantation of stent(s) or stent graft(s) in the target vessel.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

34 participants in 1 patient group

EverFlex™ stent with Entrust™ delivery system
Experimental group
Treatment:
Device: EverFlex™ stent with Entrust™ delivery system

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems